These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12516939

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
    Perry CM, Faulds D.
    Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and safety of multiple-dose valaciclovir in geriatric volunteers with and without concomitant diuretic therapy.
    Wang LH, Schultz M, Weller S, Smiley ML, Blum MR.
    Antimicrob Agents Chemother; 1996 Jan; 40(1):80-5. PubMed ID: 8787884
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.
    Kimberlin DW, Jacobs RF, Weller S, van der Walt JS, Heitman CK, Man CY, Bradley JS.
    Clin Infect Dis; 2010 Jan 15; 50(2):221-8. PubMed ID: 20014952
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.
    Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang ML, Schiffer JT, Koelle DM, Corey L, Wald A.
    Lancet; 2012 Feb 18; 379(9816):641-7. PubMed ID: 22225814
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Valaciclovir: a review of its long term utility in the management of genital herpes simplex virus and cytomegalovirus infections.
    Ormrod D, Scott LJ, Perry CM.
    Drugs; 2000 Apr 18; 59(4):839-63. PubMed ID: 10804039
    [Abstract] [Full Text] [Related]

  • 18. Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans.
    Soul-Lawton J, Seaber E, On N, Wootton R, Rolan P, Posner J.
    Antimicrob Agents Chemother; 1995 Dec 18; 39(12):2759-64. PubMed ID: 8593015
    [Abstract] [Full Text] [Related]

  • 19. Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy.
    Steingrimsdottir H, Gruber A, Palm C, Grimfors G, Kalin M, Eksborg S.
    Antimicrob Agents Chemother; 2000 Jan 18; 44(1):207-9. PubMed ID: 10602752
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
    Colin J, Prisant O, Cochener B, Lescale O, Rolland B, Hoang-Xuan T.
    Ophthalmology; 2000 Aug 18; 107(8):1507-11. PubMed ID: 10919899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.